Mikkel F.
- Country
- Denmark
- Department
- Department of Urology/ Urology Research Unit
Research Overview
Data & Insights
Has run more than one trial at 0 of 3 partner sites.
Specializations
Genitourinary Oncology
The investigator concentrates on malignancies of the urinary tract and adjacent structures, emphasizing innovative therapeutic strategies for bladder cancer and related diseases.
- Evaluation of systemic therapies for muscle-invasive bladder cancer
- Combination immunotherapy approaches in urothelial carcinoma
- Targeted treatment trials for renal cell carcinoma
- Precision medicine in bladder cancer
Collaboration with regional oncology centers supports multi‑institutional enrollment across Herlev Hospital and Region Hovedstadens.
Kidney Disease and Nephrology
Research includes chronic renal disorders and related metabolic complications, focusing on disease mechanisms and therapeutic modulation.
- Biomarker discovery in chronic kidney disease
- Therapeutic modulation of proteinuria in glomerulonephritis
- Cardiovascular risk management in patients on dialysis
- Intervention studies for adynamic bone disorder in renal disease
Integration of nephrology and urology expertise enhances translational impact.
Urinary Tract Infections and Lower Urinary Tract Disorders
Focus is on bacterial infections of the urinary system and strategies to reduce recurrence and antimicrobial resistance.
- Preventive protocols for complicated urinary tract infection
- Evaluation of prophylactic regimens in catheter‑associated urinary tract infection
- Impact of microbiome modulation on urinary tract infection recurrence
- Safety assessments of novel antibiotics targeting antimicrobial resistance
Data are collected across Herlev Hospital and Region Hovedstadens sites.
Prostate Cancer Therapeutics
Investigations target advanced prostate malignancies, including hormone‑resistant disease and precision‑guided treatment pathways.
- Combination strategies with androgen deprivation therapy in prostate cancer
- Novel agents for metastatic castration‑resistant prostate cancer
- Biomarker‑guided selection for treatment escalation in prostate cancer
- Imaging criteria for early detection of PSA progression
Clinical endpoints include survival and quality‑of‑life metrics.
Rare Urologic Tumors
The investigator also addresses uncommon neoplasms within the urinary tract, applying molecular profiling to inform therapy.
- Therapeutic evaluation in upper tract urothelial carcinoma
- Clinical assessment of small cell carcinoma of the bladder
- Management pathways for vulvar squamous cell carcinoma with urologic involvement
- Molecular profiling of rare genitourinary tumors
Rare disease registries support patient identification and longitudinal follow‑up.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.